Results 181 to 190 of about 20,737 (301)

Transient Hyperprolactinemia Associated With Semaglutide in a Patient With Hashimoto's Thyroiditis. [PDF]

Case Rep Med
Guimarães GNF.
europepmc   +1 more source

Neonatal Surveillance Gaps in Maternal Graves' Disease: Findings From a Queensland Maternity Hospital

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.
ABSTRACT Background Graves' disease presents unique challenges in pregnancy due to the risk of neonatal morbidity and mortality from maternal TSH Receptor antibodies (TRAb). A maternity hospital in Queensland has implemented a policy to identify at‐risk neonates and facilitate follow‐up, including cord blood TRAb, thyroid function tests (TFTs), and ...
Umesha Pathmanathan, Annabel Wingate, Stephanie Teasdale   +2 more
wiley   +1 more source

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

GRKs and arrestins: Nomenclature and functions in GPCR‐dependent and ‐independent signalling

British Journal of Pharmacology, Volume 183, Issue 11, Page 2619-2633, June 2026.
G protein‐coupled receptor (GPCR) kinases (GRKs) and arrestins play a critical role in the regulation of GPCR signalling. Historic names of mammalian GRKs were replaced by systematic ones in the 1990s; however, both kinds of names are currently in use for mammalian arrestins.
Vsevolod V. Gurevich
wiley   +1 more source

Pre‐RAI Monocyte‐to‐Lymphocyte Ratio Predicts Early and Higher Recurrence Risk in Intermediate‐Risk DTC, While PNI and NRI Show No Prognostic Value

Clinical Endocrinology, Volume 104, Issue 6, Page 670-681, June 2026.
ABSTRACT Objective Differentiated thyroid carcinoma (DTC) has an excellent prognosis, but recurrence remains a clinical concern, especially in intermediate‐risk patients. Current stratification systems focus primarily on tumor characteristics, overlooking the host's biological capacity to counteract tumor progression.
Tommaso Piticchio, Francesco Galeano, Salvatore Volpe, Antonio Prinzi, Ignazio Barca, Andrea Scuto, Rosario Le Moli, Giulio Geraci, Andrea Tumminia, Sium Wolde Sellasie, Francesco Pallotti, Francesco Frasca   +11 more
wiley   +1 more source

TRH can stimulate the release of two POMC-derived pituitary hormones, ACTH and MSH, in medaka.

Endocrinology
Yamakawa M, Gajbhiye DS, Golan M, Kanda S.   +3 more
europepmc   +1 more source

Thyroid Response to Peripheral Endocrine Factors: Neuropeptide Y Influences Thyroid Function in the Reptile <i>Podarcis siculus</i>. [PDF]

Int J Mol Sci
Sciarrillo R, Lallo A, Carrella F, Gallicchio V, Mileo A, Valvano BS, De Falco M.   +6 more
europepmc   +1 more source

Thyroid growth stimulating activity in higly purified lgG-fractions of patients with nonimmune thyroid diseases [PDF]

Oethinger, M. D., Scriba, Peter Christian, Wenzel, B. E.   +2 more
core   +1 more source

Effective treatment of pretibial myxoedema with tofacitinib: a case report and analysis of immunopathogenesis. [PDF]

Thyroid Res
Zhao CX, Zhao MD, Li X.
europepmc   +1 more source

Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Sodium glucose cotransporter‐2 (SGLT2) inhibitors are a class of antidiabetics with benefits including HbA1c‐lowering, weight loss, cardiovascular and renal protection in addition to adverse effects including genitourinary tract infections, ketoacidosis, and bone loss.
May E. Montasser, Salma A. Bargal, Elizabeth A. Streeten, Hilary B. Whitlatch, Zhinous Shahidzadeh Yazdi, Jordin Sirody, Rosanna Kiplagat, Merna Beshara, Jeffrey R. O’Connell, Simeon I. Taylor, Amber L. Beitelshees   +10 more
wiley   +1 more source